Association of GLP-1 inhibitors with cardiovascular outcomes in patients undergoing coronary artery bypass surgery
Authors:
- 17 February 2026
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 172 (3) , 591-599.e5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Do Outcomes After Cardiac Surgery Differ by Preoperative Status and Socioeconomic Deprivation?Annals of Thoracic Surgery Short Reports, 2025
- Late-Breaking Clinical Trials and Science: Clinical Trials Updates and Registries IIHeart Rhythm, 2025
- Multi-society clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative periodSurgical Endoscopy, 2024
- A systematic review and meta-analysis of differences between men and women in short-term outcomes following coronary artery bypass graft surgeryScientific Reports, 2024
- Semaglutide and Cardiovascular Outcomes in Obesity without DiabetesNew England Journal of Medicine, 2023
- Prevention and Treatment of Atrial Fibrillation via Risk Factor ModificationThe American Journal of Cardiology, 2021
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine, 2016
- Liraglutide and Cardiovascular Outcomes in Type 2 DiabetesNew England Journal of Medicine, 2016
- 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort studyThe Lancet, 2015
- Exenatide Reduces Infarct Size and Improves Cardiac Function in a Porcine Model of Ischemia and Reperfusion InjuryJACC, 2009